Home » FDA’s User Fee Proposal Places Greater Emphasis on Drug Safety
FDA’s User Fee Proposal Places Greater Emphasis on Drug Safety
February 15, 2007
Improved drug safety is foremost in the FDA’s Prescription Drug User Fee Act (PDUFA) proposal that seeks new authority and more than $29 million in additional fees specifically to improve its postmarket safety surveillance.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor